JDD Webinars

Actinic Keratosis: Current Understanding of Pathophysiology and Therapeutic Targets

By April 9, 2021August 19th, 2024No Comments

JDD Multimedia

Actinic Keratosis: Current Understanding of Pathophysiology and Therapeutic Targets

Featuring Brian Berman, MD, PhD

Join JDD for Part One of this two-part webinar series on “Advancing the Understanding of Actinic Keratosis: New Treatment Options and Strategies.” In this continuing education activity, faculty will explore the pathophysiology and differential diagnosis of actinic keratosis. Dr. Berman will review understanding of therapeutic targets of AK treatment approaches.

Upon completion of this enduring, internet-based webinar, participants should be able to:

  • Review current understanding of the pathophysiology and differential diagnosis of actinic keratosis
  • Discuss therapeutic targets of actinic keratosis treatment strategies

Faculty


Brian Berman, MD, PhD
Emeritus Professor of Dermatology and Cutaneous Surgery
University of Miami Miller School of Medicine, Miami, FL
Co-Director, Center for Clinical and Cosmetic Research, Miami Beach, Florida

You May Also Like

Prevention is the Best Medicine: ADing up the Data

| Atopic Dermatitis, CME Activities, Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments
iTunes TuneIn Spotify Dr. Candrice Heath, Dr. Jonathan O’B. Hourihane & Dr. Adam Friedman Continue to CME Activity Atopic Dermatitis (AD) is the second most common chronic inflammatory (coming for…

Leave a Reply